NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT03649321
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer treatment 1 / 2 terminated NCT04164602
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly No drug interventions Not Available Not Available recruiting NCT03607643
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies treatment 1 / 2 unknown_status NCT05361954
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05111353
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery treatment 1 recruiting NCT05496777
Home-based Prehabilitation in Pancreatic Resection No drug interventions basic_science Not Available completed NCT06148298
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer No drug interventions Not Available Not Available recruiting NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations No drug interventions treatment 1 recruiting NCT03536793
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection No drug interventions Not Available Not Available recruiting NCT02905578
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) treatment 2 active_not_recruiting NCT03150615
Enteral Nutrition After Pancreaticoduodenectomy No drug interventions prevention Not Available completed NCT04008537
Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device No drug interventions device_feasibility Not Available completed NCT04128332
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer No drug interventions other Not Available unknown_status NCT03122106
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy No drug interventions treatment 1 terminated NCT02296736
The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan No drug interventions Not Available Not Available completed NCT04258813
Onco-primary Care Networking to Support TEAM-based Care No drug interventions prevention Not Available recruiting NCT03883919
Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy treatment 1 completed NCT02044224
Effects of Dexmedetomidine During IRE Procedures for Solid Tumours treatment 4 completed NCT03719716
Early Support in Primary Care for People Starting Treatment for Cancer No drug interventions supportive_care Not Available completed NCT01313416
Gemcitabine and CT-011 for Resected Pancreatic Cancer treatment 2 terminated NCT01446458
Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer treatment 1 completed NCT04809935
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy treatment 4 unknown_status NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) No drug interventions Not Available Not Available completed NCT02311439
Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas No drug interventions treatment 2 / 3 unknown_status NCT02524925
Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or Pancreatectomy No drug interventions supportive_care Not Available completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04123574
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer treatment 0 withdrawn NCT01420874
Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) treatment 1 completed NCT05485974
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation No drug interventions treatment 1 recruiting NCT02830620
Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy No drug interventions basic_science Not Available completed NCT02352831
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 / 2 terminated NCT02682394
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas No drug interventions Not Available Not Available unknown_status NCT04542291
Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition treatment 1 completed NCT02608229
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer treatment 1 terminated NCT04677244
Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level No drug interventions supportive_care Not Available recruiting NCT03323944
CAR T Cell Immunotherapy for Pancreatic Cancer No drug interventions treatment 1 recruiting NCT04971304
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars Not Available Not Available completed NCT03891472
Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer treatment 2 completed NCT03961646
Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRI No drug interventions Not Available Not Available completed NCT03245346
Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery No drug interventions supportive_care Not Available unknown_status NCT01677312
Trial Comparing 19 and 25-gauge EUS-FNA Needles No drug interventions diagnostic Not Available completed NCT04769414
Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) treatment 2 completed NCT02374255
Improving Goals of Care Discussion in Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT06316908
Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach supportive_care 4 completed NCT05566743
A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas other 2 recruiting NCT02902484
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer treatment 1 / 2 terminated NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT03977233
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer treatment 2 recruiting NCT04536077
Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients treatment 2 terminated NCT05163977
Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy No drug interventions treatment Not Available unknown_status NCT01231347
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas treatment 3 completed NCT05830097
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02311361
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer treatment 1 / 2 completed NCT04049461
Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05975593
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial No drug interventions diagnostic Not Available recruiting NCT06344507
Iconographic Registry of Pancreatobiliary Endoscopy Procedures No drug interventions Not Available Not Available recruiting NCT02333409
Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer No drug interventions treatment Not Available terminated NCT03956056
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy treatment 1 terminated NCT03278015
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients treatment 2 unknown_status NCT03822936
Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma treatment 2 unknown_status NCT04331041
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma treatment 2 recruiting NCT01838317
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas treatment 2 completed NCT02681796
Epidural Analgesia Use in Pancreatic Resections supportive_care 1 completed NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT05041335
Wet Heparinized Suction for Abdominal Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT02950025
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies No drug interventions treatment 2 terminated NCT03821025
Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT00613730
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint treatment 2 terminated NCT05470166
Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity. health_services_research Not Available completed NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients No drug interventions diagnostic 2 recruiting NCT03451773
M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas treatment 1 / 2 terminated NCT06046794
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients No drug interventions other Not Available not_yet_recruiting NCT03347162
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03659292
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy No drug interventions supportive_care Not Available unknown_status NCT02681601
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer No drug interventions treatment Not Available terminated NCT02669914
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors treatment 2 terminated NCT05234450
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas No drug interventions Not Available Not Available unknown_status NCT02442323
A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients No drug interventions supportive_care Not Available completed NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions supportive_care Not Available not_yet_recruiting NCT06621095
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) treatment 2 not_yet_recruiting NCT02830724
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers treatment 1 / 2 recruiting NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers No drug interventions Not Available Not Available recruiting NCT03190941
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients treatment 1 / 2 recruiting NCT03269994
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? treatment 3 active_not_recruiting NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow No drug interventions Not Available Not Available recruiting NCT03745326
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients treatment 1 / 2 recruiting NCT03851133
Florida Pancreas Collaborative Next Generation Biobank No drug interventions Not Available Not Available active_not_recruiting NCT04157127
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma No drug interventions treatment 1 active_not_recruiting NCT04611867
Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) No drug interventions supportive_care Not Available recruiting NCT04632303
Early Palliative Care for Patients with Advanced Pancreatic Cancer. No drug interventions supportive_care Not Available active_not_recruiting NCT04683939
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors treatment 1 / 2 terminated NCT05086250
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients with Pancreatic Cancer supportive_care 0 recruiting NCT05169437
Niraparib in the Treatment of Patients with Advanced PALB2 Mutated Tumors treatment 2 terminated NCT05196334
Pharmacotyping of Pancreatic Patient-derived Organoids No drug interventions Not Available Not Available recruiting NCT05600933
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment No drug interventions Not Available Not Available enrolling_by_invitation NCT05687188
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations No drug interventions Not Available Not Available recruiting NCT05721846
Nivolumab with Ipilimumab Combined with TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer treatment 1 recruiting NCT06625320
Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) treatment 3 recruiting NCT05922930
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer treatment 1 / 2 recruiting NCT06282809
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy No drug interventions treatment Not Available recruiting NCT06423963
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer No drug interventions supportive_care Not Available recruiting NCT04553926
'OLAP' (OLAparib Regulatory Post-marketing Surveillance) No drug interventions Not Available Not Available recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors treatment 1 completed NCT04751435
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients No drug interventions health_services_research Not Available recruiting NCT04807972
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis treatment 1 / 2 terminated NCT04984174
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan No drug interventions Not Available Not Available recruiting NCT05162846
Methods for Increasing Genetic Testing Uptake in Michigan No drug interventions health_services_research Not Available recruiting NCT05188586
New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) No drug interventions screening Not Available terminated NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05277766
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal Cancer treatment 1 recruiting NCT05298722
Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) No drug interventions diagnostic Not Available recruiting NCT05336266
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma supportive_care 0 active_not_recruiting NCT05518110
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer treatment 2 recruiting NCT05675059
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients No drug interventions supportive_care Not Available recruiting NCT05776524
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer treatment 2 suspended NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06026943
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available not_yet_recruiting NCT06166147
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection No drug interventions Not Available Not Available recruiting NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06323291
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study No drug interventions health_services_research 0 recruiting NCT06334432
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients with Solid Tumors No drug interventions diagnostic 1 recruiting NCT06378047
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer treatment 1 recruiting NCT06411691
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer treatment 2 not_yet_recruiting NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT06479239
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer No drug interventions treatment 1 / 2 recruiting NCT06564623
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) treatment 1 not_yet_recruiting NCT06587061
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer No drug interventions treatment 2 not_yet_recruiting NCT06589102
Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery No drug interventions Not Available Not Available completed NCT06614751
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway No drug interventions treatment 1 not_yet_recruiting NCT06617169
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors treatment 1 not_yet_recruiting NCT06598033
Vitamin C Plus Herbal Medicine to Quality of Life in Patients with Terminal Stage Pancreatic Cancer No drug interventions treatment 2 / 3 not_yet_recruiting NCT06601010
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer. No drug interventions Not Available Not Available not_yet_recruiting NCT06601283
Vitamin C Plus Herbal Medicine to Chemotherapy Related Anemia in Pancreatic Cancer No drug interventions treatment 2 / 3 not_yet_recruiting NCT02704143
Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available completed NCT01774643
A Study of Pancreatic Cancer in Xenografts From Liver Metastases No drug interventions Not Available Not Available completed NCT04477343
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 recruiting NCT00900003
Studying Biomarkers in Patients With Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02393703
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT02798003
Food Reward in Cachexia Induced by Acute or Chronic Disease No drug interventions Not Available Not Available terminated NCT04387903
Reoperation After Pancreaticoduodenectomy No drug interventions Not Available Not Available unknown_status NCT02132403
(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer treatment 1 terminated NCT01641003
Isolation and Characterization of Cancer Stem Cells Using iFP Technique No drug interventions Not Available Not Available unknown_status NCT01351103
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands treatment 1 active_not_recruiting NCT00967603
Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer treatment 2 completed NCT01895790
Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer No drug interventions supportive_care 1 / 2 withdrawn NCT00004190
Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT05524090
PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT01326364
Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection Not Available Not Available terminated NCT00587964
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases No drug interventions treatment 2 completed NCT00408564
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT06447064
Cancer Loyalty Card Study 2 (CLOCS-2) No drug interventions Not Available Not Available recruiting NCT04290364
Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study No drug interventions Not Available Not Available completed NCT03492164
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer No drug interventions basic_science 0 terminated NCT01373164
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer treatment 1 / 2 completed NCT03069664
Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer No drug interventions supportive_care Not Available unknown_status NCT03820921
Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT06203821
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer No drug interventions treatment 1 not_yet_recruiting NCT03443921
Divestment for Artery-involved Pancreatic Cancer treatment Not Available unknown_status NCT06043921
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel No drug interventions Not Available Not Available recruiting NCT01198821
Gem-TABS in Unresectable Pancreatic Carcinoma treatment 1 completed NCT00994721
A Phase III Study of Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00027521
Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer treatment 1 withdrawn NCT03200821
An Open Label Study to Evaluate G17DT Compared to Gemcitabine treatment 3 completed NCT02923921
Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer treatment 3 completed NCT05984602
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer treatment 1 recruiting NCT05138302
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients No drug interventions Not Available Not Available unknown_status NCT02954302
Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy No drug interventions prevention Not Available unknown_status NCT00648102
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer No drug interventions treatment 1 completed NCT01659502
Investigator's Initiated Phase II Study for Pancreatic Cancer Patients No drug interventions treatment 2 unknown_status NCT00906802
Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy No drug interventions prevention Not Available unknown_status NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors No drug interventions Not Available Not Available completed NCT01386502
CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors treatment 1 withdrawn NCT04409002
Niraparib + Dostarlimab + RT in Pancreatic Cancer treatment 2 completed NCT00019084
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer treatment 2 completed NCT00004884
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer treatment 2 completed NCT05350384
An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy Not Available Not Available completed NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT01978184
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine treatment 2 completed NCT04925284
Study of XB002 in Subjects With Solid Tumors (JEWEL-101) treatment 1 active_not_recruiting NCT04764084
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors treatment 1 unknown_status NCT00225784
Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer treatment 2 completed NCT01268384
Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer treatment 2 completed NCT00004879
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer treatment 1 completed NCT03161379
GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer treatment 2 completed NCT04820179
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer treatment 2 recruiting NCT02446379
Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery No drug interventions Not Available Not Available withdrawn NCT04002479
Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT00578279
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study treatment 4 completed NCT00540579
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas treatment 1 / 2 completed NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT05658679
Radiomics in Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05141643
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer No drug interventions diagnostic 0 recruiting NCT03300843
Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer No drug interventions treatment 2 terminated NCT04894643
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer other Not Available recruiting NCT03152487
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis No drug interventions treatment Not Available completed NCT00565487
Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer treatment 1 completed NCT03768687
A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT04509687
Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions No drug interventions Not Available Not Available unknown_status NCT03139487
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism treatment 2 unknown_status NCT04046887
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) treatment 1 terminated NCT05842187
In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer No drug interventions treatment Not Available recruiting NCT00599833
Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery treatment 2 completed NCT01563133
Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas No drug interventions diagnostic Not Available unknown_status NCT01175733
Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer treatment 1 / 2 completed NCT00126633
Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT00642733
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer treatment 4 terminated NCT05251233
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy supportive_care 2 terminated NCT05411133
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients No drug interventions treatment 1 recruiting NCT01146054
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma treatment 2 completed NCT00691054
Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy treatment 2 completed NCT03510754
Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP No drug interventions Not Available Not Available completed NCT03599154
Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy No drug interventions Not Available Not Available completed NCT05585554
Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy No drug interventions treatment Not Available not_yet_recruiting NCT01339754
Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy treatment 2 completed NCT00243854
Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer treatment 1 completed NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) treatment 1 / 2 terminated NCT06370754
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment treatment 1 / 2 not_yet_recruiting NCT01342354
Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer No drug interventions treatment 1 / 2 unknown_status NCT06375954
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial) No drug interventions treatment Not Available not_yet_recruiting NCT00415454
Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma No drug interventions treatment 1 terminated NCT00003851
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer treatment Not Available terminated NCT00262951
Chemoradiation in Locally Advanced Pancreatic Cancer treatment 2 terminated NCT00014651
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection supportive_care 3 terminated NCT04291651
UCSF PANC Cyst Registry No drug interventions Not Available Not Available recruiting NCT00066651
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT02908451
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer No drug interventions treatment 1 terminated NCT00064051
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer treatment 2 completed NCT00179751
A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas treatment 1 / 2 terminated NCT04310553
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT02919553
Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions No drug interventions diagnostic Not Available withdrawn NCT01935453
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer No drug interventions treatment 1 completed NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT06378853
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients No drug interventions Not Available Not Available completed NCT02900677
Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery No drug interventions supportive_care Not Available unknown_status NCT00966277
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients treatment 4 completed NCT00066677
Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer treatment 2 terminated NCT03524677
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis No drug interventions Not Available Not Available unknown_status NCT01542177
A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02068677
Evaluation of Injection Techniques in Celiac Plexus Neurolysis No drug interventions Not Available Not Available completed NCT00795977
Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer treatment 1 / 2 unknown_status NCT01811277
SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer treatment 2 unknown_status NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors treatment 1 completed NCT00003677
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT05977777
Contrast-enhanced Ultrasound and Pancreatic Lesions No drug interventions diagnostic Not Available recruiting NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04311047
Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI No drug interventions diagnostic Not Available terminated NCT02745847
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer No drug interventions treatment Not Available active_not_recruiting NCT02550847
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT03809247
Microbial Diversity of Pancreatic Diseases No drug interventions Not Available Not Available recruiting NCT06427447
Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) No drug interventions treatment 3 recruiting NCT00121745
Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer No drug interventions treatment 1 terminated NCT02843945
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source No drug interventions treatment 1 / 2 recruiting NCT04024345
The Emotional Impact of Surveillance for Pancreatic Cancer No drug interventions diagnostic Not Available unknown_status NCT01335945
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer No drug interventions supportive_care 1 terminated NCT00225745
Ghrelin Levels in Pancreatic Cancer Patients No drug interventions Not Available Not Available completed NCT04637698
OH2 Oncolytic Viral Therapy in Pancreatic Cancer treatment 1 / 2 terminated NCT02400398
Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients No drug interventions Not Available Not Available completed NCT05355298
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer treatment 1 / 2 recruiting NCT02289898
Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 completed NCT02643498
A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer No drug interventions treatment 1 active_not_recruiting NCT03717298
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma No drug interventions supportive_care 2 completed NCT03127098
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer treatment 1 / 2 terminated NCT03387098
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy treatment 1 / 2 terminated NCT01472198
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma treatment 2 completed NCT00504998
Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT00003798
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery treatment 1 completed NCT00559598
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer No drug interventions Not Available Not Available completed NCT04834505
To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound No drug interventions Not Available Not Available recruiting NCT01364805
New Treatment Option for Pancreatic Cancer treatment 1 completed NCT03301805
A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer treatment 2 not_yet_recruiting NCT06069297
Prehabilitation in Pancreatic Surgery No drug interventions prevention Not Available recruiting NCT02745197
A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer No drug interventions basic_science 2 withdrawn NCT04293497
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer No drug interventions diagnostic Not Available completed NCT05329597
Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT05494697
Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma treatment 2 recruiting NCT00003797
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas treatment 2 unknown_status NCT04683497
CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial No drug interventions diagnostic Not Available unknown_status NCT01646697
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery No drug interventions diagnostic Not Available completed NCT05605197
U87 CART in Treatment of Advanced Solid Tumor No drug interventions treatment 1 recruiting NCT02024997
Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study No drug interventions basic_science 0 completed NCT05351983
Patient-derived Organoids Drug Screen in Pancreatic Cancer No drug interventions other Not Available recruiting NCT01858883
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT03244683
A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery No drug interventions treatment Not Available terminated NCT00062283
Alanosine in Treating Patients With Cancer treatment 2 completed NCT02138383
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer treatment 1 completed NCT05679583
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer No drug interventions treatment 2 recruiting NCT00084383
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas No drug interventions treatment 2 completed NCT01094561
Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients diagnostic Not Available completed NCT02191761
Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer No drug interventions treatment 1 completed NCT02358161
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer treatment 1 / 2 completed NCT06541561
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy No drug interventions treatment Not Available not_yet_recruiting NCT04427761
A Study of the Life Changes Experienced by Patients With Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01510561
A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. treatment 1 withdrawn NCT01103128
Validation of a Mouse Model of Pancreatic Carcinogenesis No drug interventions Not Available Not Available terminated NCT01589328
Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB No drug interventions supportive_care Not Available completed NCT04210128
Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment No drug interventions Not Available Not Available completed NCT02340728
Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies No drug interventions treatment 3 completed NCT04373928
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT00112528
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT01781728
Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma No drug interventions health_services_research 2 active_not_recruiting NCT00324428
TMS for the Treatment of Pancreatic Cancer Pain No drug interventions treatment Not Available completed NCT05225428
Video Education With Result Dependent dIsclosure No drug interventions health_services_research Not Available recruiting NCT02260128
Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery No drug interventions treatment Not Available unknown_status NCT00806611
Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer No drug interventions supportive_care 3 completed NCT05546411
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer treatment 2 terminated NCT01608711
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 treatment 2 completed NCT05714111
Radiology Registry on Pancreatic Malignancies No drug interventions Not Available Not Available recruiting NCT02027311
Etomidate vs. Midazolam for Sedation During ERCP treatment 4 completed NCT00268411
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer treatment 3 unknown_status NCT03374293
Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT00290693
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer treatment 2 completed NCT04189393
Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery No drug interventions Not Available Not Available unknown_status NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers treatment 2 recruiting NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06196671
Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT03886571
U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT00005871
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer treatment 3 unknown_status NCT02403271
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 / 2 completed NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking treatment 4 completed NCT01908478
Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer treatment 1 completed NCT06159478
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) treatment 2 recruiting NCT01888978
Molecularly Tailored Therapy for Pancreas Cancer treatment 2 completed NCT04048278
Lidocaine Infusion in Pancreatic Cancer treatment 0 recruiting NCT02042378
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation treatment 2 completed NCT04183478
The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer treatment 2 / 3 unknown_status NCT00185588
Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer treatment 1 / 2 completed NCT03165188
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy No drug interventions Not Available Not Available terminated NCT06008288
A Study of JAB-21822 in Patients With KRAS p.G12C Mutated Pancreatic Cancer treatment 2 recruiting NCT05831488
Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer No drug interventions Not Available Not Available recruiting NCT01768988
Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study treatment 4 terminated NCT04666688
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT00779688
A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers No drug interventions Not Available Not Available completed NCT00096707
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors treatment 1 completed NCT05723107
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) No drug interventions treatment 1 recruiting NCT00836407
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer treatment 1 completed NCT00064207
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer treatment 2 / 3 completed NCT04805307
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 treatment 1 recruiting NCT01581307
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets treatment 2 completed NCT04037007
Efficacy of Fistulotomy for Biliary Cannulation No drug interventions treatment Not Available unknown_status NCT06508307
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors treatment 1 recruiting NCT01717807
C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). No drug interventions Not Available Not Available unknown_status NCT03129607
A Study in Postoperative Pancreatic Fistula No drug interventions Not Available Not Available unknown_status NCT00101907
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer treatment 1 terminated NCT00416507
Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT04316507
Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients No drug interventions health_services_research Not Available unknown_status NCT04033107
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors treatment 2 recruiting NCT02948309
Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer No drug interventions treatment 3 completed NCT06093009
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer No drug interventions Not Available Not Available completed NCT01838109
Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery No drug interventions treatment Not Available completed NCT02457156
Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy treatment 3 unknown_status NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients No drug interventions diagnostic Not Available recruiting NCT01822756
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors treatment 1 terminated NCT06344156
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer No drug interventions treatment 1 recruiting NCT04318756
The Italian Version of Cancer Worry Scale No drug interventions Not Available Not Available unknown_status NCT06478056
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma No drug interventions other Not Available recruiting NCT03515356
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy No drug interventions supportive_care Not Available completed NCT03512756
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer treatment 2 / 3 completed NCT01324856
Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy No drug interventions treatment 1 unknown_status NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01031056
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers No drug interventions Not Available Not Available withdrawn NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia No drug interventions Not Available Not Available completed NCT01385956
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer treatment 1 completed NCT00113256
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer treatment 2 / 3 terminated NCT00003085
Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer No drug interventions diagnostic 2 terminated NCT00720785
Natural Killer Cells and Bortezomib to Treat Cancer treatment 1 completed NCT02079285
Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation No drug interventions Not Available Not Available completed NCT04846985
Nutritional Problems in Pallative Cancer No drug interventions Not Available Not Available completed NCT01438385
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders No drug interventions Not Available Not Available unknown_status NCT04814485
Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer treatment 2 unknown_status NCT00855985
Anastomotic Techniques in Pancreaticoduodenectomy No drug interventions treatment Not Available unknown_status NCT04415385
The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma treatment 2 unknown_status NCT05660915
A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy No drug interventions treatment Not Available recruiting NCT02209415
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer No drug interventions diagnostic Not Available unknown_status NCT05906615
Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis treatment 2 completed NCT04922515
Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes No drug interventions diagnostic Not Available unknown_status NCT00100815
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer treatment 2 completed NCT00581815
Spectroscopy With Surface Coils and Decoupling No drug interventions diagnostic 1 completed NCT05919537
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation treatment 1 recruiting NCT02921737
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) treatment 2 terminated NCT02399137
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer treatment 2 completed NCT01845337
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine treatment 2 completed NCT06395337
Multimodal Imaging in Rectal Cancer & Pancreatic Cancer No drug interventions other 1 / 2 not_yet_recruiting NCT03016637
Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy No drug interventions diagnostic 1 / 2 completed NCT01248637
Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole No drug interventions Not Available Not Available completed NCT00379132
131-I-TM-601 Study in Adults With Solid Tumors treatment 1 completed NCT04813432
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas No drug interventions Not Available Not Available unknown_status NCT00025532
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer No drug interventions treatment 1 withdrawn NCT00899132
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT01836432
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer treatment 3 terminated NCT02868632
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer treatment 1 withdrawn NCT00003332
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer treatment 1 / 2 completed NCT00068432
Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT03792932
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT00030732
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer treatment 3 completed NCT01430052
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer treatment 2 completed NCT00769652
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer No drug interventions supportive_care Not Available terminated NCT01801852
Autologous Natural Killer T Cells Infusion for the Treatment of Cancer No drug interventions treatment Not Available unknown_status NCT02659852
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT00075452
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma treatment 3 unknown_status NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT02020252
Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials No drug interventions Not Available Not Available completed NCT06578052
Irinotecan Liposome in Combination With Capecitabine treatment Not Available not_yet_recruiting NCT02810652
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection No drug interventions supportive_care Not Available completed NCT02674100
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry No drug interventions Not Available Not Available recruiting NCT00102700
ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer treatment 2 completed NCT01989000
The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome diagnostic Not Available completed NCT01094600
Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency diagnostic Not Available withdrawn NCT00336700
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer treatment 2 terminated NCT03902600
Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-metastatic Pancreas Cancer With Assessment of Treatment Response Utilizing Molecular Biomarkers No drug interventions Not Available Not Available active_not_recruiting NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT05394259
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer diagnostic 1 recruiting NCT02042859
Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer No drug interventions treatment 1 unknown_status NCT06015659
ZN-c3 + Gemcitabine in Pancreatic Cancer treatment 2 recruiting NCT02952859
Impact of Margin-accentuation IRE in Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT03215459
Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT02718859
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer treatment 1 / 2 completed NCT01676259
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer treatment 2 unknown_status NCT00078975
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer treatment 2 completed NCT00068575
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer treatment 2 completed NCT04883775
Study of a New Technique for Imaging Pancreatic Cancer No drug interventions diagnostic 1 active_not_recruiting NCT02743975
Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma diagnostic 1 / 2 terminated NCT01642875
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy No drug interventions prevention 4 unknown_status NCT05836870
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer No drug interventions supportive_care 3 recruiting NCT00401570
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer treatment 2 completed NCT06411470
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis No drug interventions Not Available Not Available recruiting NCT06313970
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients treatment 2 not_yet_recruiting NCT00660270
Chemotherapy and Radiation Following Pancreatic Surgery treatment 2 completed NCT00536770
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer treatment 2 suspended NCT03140670
Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy treatment 2 terminated NCT00005870
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas treatment 3 unknown_status NCT02428270
A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer treatment 2 completed NCT01941342
Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy No drug interventions prevention 2 unknown_status NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells treatment 1 recruiting NCT03086642
Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer treatment 1 active_not_recruiting NCT06139042
Early-stage Detection of LIver, Biliary tRAct and pancReatic Cancers No drug interventions Not Available Not Available recruiting NCT06217042
HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer treatment 3 not_yet_recruiting NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S No drug interventions treatment 1 completed NCT05139199
Effectiveness of Auricular Point Acupressure in Improving Quality of Life in Patients With Pancreatic Cancer No drug interventions supportive_care Not Available completed NCT04130399
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer No drug interventions treatment 2 withdrawn NCT00660699
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers treatment 2 completed NCT02887599
Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities No drug interventions diagnostic Not Available completed NCT00008099
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer No drug interventions treatment 1 completed NCT00582699
Depression, Cytokines and Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02000999
Diagnosis of Bile Duct Strictures No drug interventions Not Available Not Available completed NCT03069599
Immune Response After Pancreatic Cancer Treatment No drug interventions Not Available Not Available terminated NCT01020006
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine treatment 2 completed NCT06539806
Clinical Study Evaluating the Effect of Losartan treatment Not Available recruiting NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01632306
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer treatment 1 / 2 terminated NCT00735306
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma treatment 1 completed NCT03136406
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy treatment 1 / 2 terminated NCT03403049
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer treatment 1 completed NCT05141149
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer treatment 1 / 2 recruiting NCT00003049
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas treatment 3 completed NCT00058149
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 3 completed NCT01560949
Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas treatment 2 completed NCT06547736
Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT06326736
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer treatment 0 recruiting NCT04137536
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer No drug interventions treatment 1 active_not_recruiting NCT00766636
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy treatment 2 terminated NCT04058236
Glycocalyx Levels in Patients Undergoing Pancreatectomy No drug interventions treatment 4 unknown_status NCT02461836
Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) treatment 2 unknown_status NCT05861336
GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer treatment 2 recruiting NCT00550836
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT01688336
FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer treatment 2 terminated NCT04070313
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan No drug interventions treatment 2 terminated NCT01038713
Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction No drug interventions treatment Not Available completed NCT01505413
Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer treatment 2 completed NCT00161213
Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer treatment 2 completed NCT05057013
HMBD-001 in Advanced HER3 Positive Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. No drug interventions treatment 1 active_not_recruiting NCT06440018
INSPIRE: A Multi-Cancer Early Detection Study No drug interventions Not Available Not Available not_yet_recruiting NCT03001518
Immunologic Signatures Following Surgery for Pancreatic Cancer No drug interventions Not Available Not Available completed NCT05064618
Investigator-initiated Clinical Trial of MIKE-1 treatment 1 / 2 recruiting NCT04151719
An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer treatment 3 withdrawn NCT03958019
Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer No drug interventions treatment Not Available recruiting NCT00077519
Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer treatment 1 completed NCT01553019
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer treatment 2 completed NCT02981719
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available completed NCT00753441
Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head No drug interventions treatment Not Available terminated NCT01320241
Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture No drug interventions treatment 2 completed NCT05430841
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT No drug interventions diagnostic Not Available unknown_status NCT00033241
Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors treatment 1 completed NCT00109941
Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT00425841
Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer treatment 2 completed NCT02565641
A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT01580241
Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00667641
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors treatment 1 completed NCT00727441
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery treatment 2 completed NCT00493441
AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer No drug interventions treatment 2 terminated NCT01655641
Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery treatment 2 / 3 unknown_status NCT00912717
Pancreatic Adenocarcinoma Gene Environment Risk Study No drug interventions Not Available Not Available recruiting NCT04323917
Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential No drug interventions Not Available Not Available unknown_status NCT01844817
Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT05911217
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer treatment 1 recruiting NCT01458717
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer No drug interventions treatment 2 / 3 completed NCT05116917
Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. treatment 2 terminated NCT02329717
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma No drug interventions treatment 2 unknown_status NCT02672917
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies treatment 1 active_not_recruiting NCT06119217
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients treatment 2 recruiting NCT00006117
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 unknown_status NCT01395017
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer treatment 2 completed NCT00855634
Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München No drug interventions treatment Not Available terminated NCT00027534
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT00003434
Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer treatment 1 terminated NCT02277834
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice No drug interventions Not Available Not Available completed NCT01071434
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors No drug interventions Not Available Not Available terminated NCT00767234
Permission to Collect Blood Over Time for Research No drug interventions Not Available Not Available terminated NCT03077334
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02349724
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer No drug interventions treatment 1 unknown_status NCT02208024
Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body No drug interventions treatment Not Available completed NCT00957424
Acceptability of Less Harmful Alternatives to Cigarettes Not Available Not Available completed NCT06298916
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer No drug interventions diagnostic 1 / 2 not_yet_recruiting NCT00467116
PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca treatment 1 completed NCT02822716
Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy No drug interventions treatment Not Available terminated NCT06371716
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions No drug interventions treatment Not Available terminated NCT00763516
Proton Radiation for Resectable Carcinoma of the Pancreas No drug interventions treatment Not Available completed NCT06361316
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer treatment Not Available recruiting NCT04330716
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers No drug interventions health_services_research Not Available completed NCT01167816
Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer treatment 1 terminated NCT01104116
Use of PET Imaging to Distinguish Malignant From Benign IPMN No drug interventions diagnostic Not Available terminated NCT04504916
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) treatment 2 terminated NCT01938716
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy basic_science Not Available terminated NCT06122896
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals No drug interventions screening 0 recruiting NCT01717196
Diagnostic Accuracy of FNA: is Aspiration- Related? No drug interventions diagnostic Not Available unknown_status NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT05462496
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer treatment 2 recruiting NCT00281996
Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer treatment 1 terminated NCT04084496
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients No drug interventions treatment 2 recruiting NCT02637596
Quality of Life After Radiofrequency Ablation of Pancreatic Cancer No drug interventions treatment Not Available completed NCT01074996
Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers treatment 2 unknown_status NCT01128296
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas treatment 1 / 2 completed NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy No drug interventions treatment 1 / 2 completed NCT01707758
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence No drug interventions Not Available Not Available withdrawn NCT01675258
Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers No drug interventions Not Available Not Available unknown_status NCT01108458
A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma treatment 2 terminated NCT00899158
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss No drug interventions Not Available Not Available completed NCT00112658
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer treatment 2 / 3 completed NCT00909558
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer No drug interventions treatment 1 suspended NCT00786058
A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 Not Available Not Available approved_for_marketing NCT06048458
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping No drug interventions Not Available Not Available recruiting NCT02278458
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer treatment 1 unknown_status NCT05428358
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery No drug interventions diagnostic Not Available recruiting NCT00005858
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer No drug interventions treatment 1 completed NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT02343835
Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer No drug interventions treatment Not Available completed NCT00019435
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03454035
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors treatment 1 recruiting NCT03953235
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens treatment 1 / 2 completed NCT05596435
Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT01041235
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies treatment 1 completed NCT00470535
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer treatment 2 terminated NCT00514163
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer treatment 2 completed NCT01296763
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer treatment 1 completed NCT00024063
SU006668 in Treating Patients With Advanced Solid Tumors treatment 1 unknown_status NCT00685763
Proton Therapy for Unresectable Cancer (CA) of Pancreas No drug interventions treatment Not Available completed NCT02777463
The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT. No drug interventions Not Available Not Available completed NCT02574663
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors treatment 1 completed NCT00944463
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients treatment 2 completed NCT00789763
Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma treatment 1 completed NCT04520386
OMT-111 for Terminal Stage Solid Tumors No drug interventions treatment 2 unknown_status NCT02305186
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer treatment 1 / 2 unknown_status NCT05525286
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma No drug interventions treatment 1 / 2 recruiting NCT02284139
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects No drug interventions treatment 2 / 3 completed NCT02098239
Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. treatment 2 completed NCT04418739
Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes prevention 2 unknown_status NCT04899739
Intraoperative Endoscopic Ultrasound for Pancreatic Cancer No drug interventions diagnostic Not Available recruiting NCT03129139
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors treatment 1 recruiting NCT02442739
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers prevention 0 withdrawn NCT00042939
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT04420039
Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction No drug interventions Not Available Not Available completed NCT06427239
Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer treatment 1 / 2 recruiting NCT04634539
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer treatment 1 active_not_recruiting NCT00128622
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer treatment 1 completed NCT02580422
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia No drug interventions Not Available Not Available terminated NCT06129422
Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer No drug interventions diagnostic 1 recruiting NCT01017822
Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer treatment 1 / 2 withdrawn NCT02116322
Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study No drug interventions diagnostic Not Available terminated NCT00402025
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer treatment 1 completed NCT06090825
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient No drug interventions Not Available Not Available recruiting NCT00003125
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors treatment 2 completed NCT03531125
Gene Expression in Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors treatment 1 completed NCT02132325
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer No drug interventions supportive_care Not Available completed NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT00634725
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery treatment 3 completed NCT00288925
Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment No drug interventions treatment 1 / 2 completed NCT04104230
Quebec Pancreas Cancer Study No drug interventions Not Available Not Available recruiting NCT05539430
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma No drug interventions treatment 1 recruiting NCT06091930
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 treatment 1 recruiting NCT04381130
A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer No drug interventions treatment 1 / 2 not_yet_recruiting NCT06254430
Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery No drug interventions Not Available Not Available completed NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT03606148
SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions No drug interventions Not Available Not Available unknown_status NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer basic_science 1 / 2 recruiting NCT01769248
Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle No drug interventions diagnostic Not Available completed NCT02662348
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System treatment 1 unknown_status NCT02646748
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors treatment 1 completed NCT04617457
Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas treatment 2 recruiting NCT01032057
Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery treatment 2 completed NCT00366457
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer treatment 2 completed NCT04452357
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer No drug interventions treatment Not Available active_not_recruiting NCT04275557
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas No drug interventions Not Available Not Available recruiting NCT00003157
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach treatment 1 completed NCT01523457
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer No drug interventions treatment 2 completed NCT05472857
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression No drug interventions treatment 1 recruiting NCT00878657
Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer treatment 1 terminated NCT00709826
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer treatment 2 completed NCT01050426
A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) No drug interventions treatment 2 terminated NCT06475326
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer treatment 2 recruiting NCT03797326
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) treatment 2 active_not_recruiting NCT00003426
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer treatment 1 completed NCT01094626
Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection diagnostic Not Available withdrawn NCT02433626
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies treatment 1 unknown_status NCT00899626
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients No drug interventions Not Available Not Available recruiting NCT00059826
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer treatment 2 completed NCT05009966
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor No drug interventions treatment 1 unknown_status NCT05494866
A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 terminated NCT01977066
Exercise Intervention Study for Pancreatic Cancer Patients No drug interventions supportive_care Not Available completed NCT00907166
A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients treatment 1 / 2 terminated NCT03998566
Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer No drug interventions treatment Not Available completed NCT03267966
Margin Status After Pancreaticoduodenectomy for Cancer No drug interventions diagnostic Not Available completed NCT02510066
Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain No drug interventions treatment 3 unknown_status NCT01947166
Pancreatic Resection, Malnutrition and Readmission No drug interventions supportive_care Not Available completed NCT00987766
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer treatment 1 completed NCT02720666
K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability treatment 1 completed NCT04380766
Covid-19 Pandemic and Pancreatic Surgery in Italy No drug interventions Not Available Not Available completed NCT00885066
Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer treatment 1 completed NCT00010166
Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas treatment 2 completed NCT03190265
Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer treatment 2 completed NCT04596865
Recurrence After Whipple's (RAW) Study No drug interventions Not Available Not Available completed NCT00882765
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery No drug interventions supportive_care 2 withdrawn NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT02670265
Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions No drug interventions supportive_care Not Available completed NCT01939665
PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma No drug interventions treatment 1 / 2 completed NCT00499265
Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT02498665
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies treatment 1 completed NCT00609765
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors treatment 2 terminated NCT00016965
BMS-247550 in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT03340974
Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer treatment 1 / 2 completed NCT06145074
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. treatment 2 recruiting NCT04306874
Whipple Protein Study No drug interventions supportive_care Not Available completed NCT01442974
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer treatment Not Available completed NCT03117920
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer treatment 2 completed NCT03138720
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer treatment 2 active_not_recruiting NCT01266720
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) treatment 1 unknown_status NCT00564720
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer treatment 2 terminated NCT00316420
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer treatment 1 completed NCT03060720
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy No drug interventions Not Available Not Available active_not_recruiting NCT03481920
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer treatment 0 terminated NCT05802420
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT01781520
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT03875820
Phase I Trial of Defactinib and VS-6766. health_services_research 1 active_not_recruiting NCT06340620
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope No drug interventions diagnostic Not Available recruiting NCT02361320
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer No drug interventions diagnostic Not Available recruiting NCT00012220
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas treatment 2 completed NCT00667082
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma other 1 completed NCT02451982
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas treatment 2 recruiting NCT04476082
Nutrition in Gastrointestinal Tumors No drug interventions Not Available Not Available completed NCT02648282
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer treatment 2 completed NCT05431582
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors treatment 1 withdrawn NCT05327582
An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC treatment 1 / 2 unknown_status NCT01025882
Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer treatment 1 terminated NCT01803282
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors treatment 1 completed NCT00826982
Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00664482
A Single-Patient Study Using AGS 006 No drug interventions treatment Not Available completed NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced Tumors No drug interventions treatment 1 recruiting NCT00352131
Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors treatment 1 completed NCT01333631
Valproic Acid With Chemoradiotherapy for Pancreatic Cancer treatment 2 unknown_status NCT02546531
Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer treatment 1 completed NCT01186731
Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer Not Available 2 completed NCT01386931
On-site Cytopathology EUS-FNA No drug interventions Not Available Not Available completed NCT04783831
Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy No drug interventions Not Available Not Available unknown_status NCT05497531
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers No drug interventions diagnostic Not Available recruiting NCT01522573
T-EUS for Gastrointestinal Disorders: A Multicenter Registry No drug interventions Not Available Not Available unknown_status NCT04581473
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection treatment 1 / 2 recruiting NCT03073473
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers No drug interventions Not Available Not Available terminated NCT01789073
Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay No drug interventions supportive_care Not Available completed NCT00767273
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx No drug interventions diagnostic Not Available completed NCT00002773
Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT03631173
Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy No drug interventions diagnostic Not Available active_not_recruiting NCT00024427
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer treatment 3 completed NCT05168527
The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients treatment 2 unknown_status NCT05500027
sCD8, as a Novel Biomarker for Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT00303927
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene treatment 2 completed NCT00426127
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer treatment 2 terminated NCT00255827
Vaccine Treatment for Surgically Resected Pancreatic Cancer treatment 1 / 2 completed NCT02431676
Survivorship Promotion In Reducing IGF-1 Trial prevention 2 completed NCT05546476
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 treatment 2 active_not_recruiting NCT04431076
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes No drug interventions Not Available Not Available active_not_recruiting NCT04425876
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer treatment 1 unknown_status NCT05014776
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer treatment 2 active_not_recruiting NCT00417976
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer treatment 2 completed NCT03517176
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer treatment 1 completed NCT00837876
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery treatment 2 completed NCT01693276
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer treatment 1 / 2 terminated NCT03205176
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas treatment 1 completed NCT01438476
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas No drug interventions treatment 3 completed NCT01794676
Genetic Evaluation of Families With Endocrine Cancers No drug interventions Not Available Not Available completed NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT02080260
A Study of Regorafenib in Advanced Pancreatic Cancer Patients treatment 2 completed NCT06134960
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor No drug interventions treatment 1 not_yet_recruiting NCT00369460
Changes in Muscle Tissue in Patients With Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00003760
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer treatment 2 completed NCT02206360
Pancreatic Cancer Early Detection Program No drug interventions Not Available Not Available active_not_recruiting NCT00088660
PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen No drug interventions treatment 3 unknown_status NCT00383760
Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients treatment 2 completed NCT02628860
Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy treatment 2 completed NCT06389760
Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer treatment 2 recruiting NCT06427460
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) No drug interventions treatment 2 recruiting NCT06435260
To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer treatment 2 recruiting NCT06210360
Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX treatment 2 not_yet_recruiting NCT00305760
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer treatment 2 completed NCT05076760
MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer treatment 1 recruiting NCT00313560
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) treatment 2 completed NCT05755594
A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy No drug interventions treatment Not Available not_yet_recruiting NCT01401894
Perception Prognosis, Goals of Treatment, and Communication No drug interventions Not Available Not Available completed NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Not Available Not Available available NCT02960594
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse prevention 1 completed NCT00005594
ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas treatment 2 completed NCT05535894
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT00900094
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer No drug interventions Not Available Not Available completed NCT00897494
Identification of Biomarkers for Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available completed NCT01760694
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer No drug interventions treatment Not Available terminated NCT03724994
Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer Not Available Not Available recruiting NCT00902291
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer treatment 2 completed NCT00005591
Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas treatment 2 withdrawn NCT03398291
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy No drug interventions treatment 3 recruiting NCT02098291
An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma treatment 2 completed NCT00967291
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer treatment 2 terminated NCT04361162
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer treatment 2 active_not_recruiting NCT00411762
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma treatment 1 / 2 completed NCT06151262
A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer treatment 2 recruiting NCT05642962
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 / 2 recruiting NCT03599362
Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer treatment 2 terminated NCT01416662
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery treatment 2 completed NCT01012362
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors treatment 1 terminated NCT03777462
Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 treatment 2 recruiting NCT04808362
Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours No drug interventions treatment 1 / 2 terminated NCT05193162
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases No drug interventions Not Available Not Available recruiting NCT03065062
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors treatment 1 recruiting NCT03585062
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer treatment 2 terminated NCT02646462
Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT04054362
Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 unknown_status NCT03331562
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer treatment 2 completed NCT05589480
Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection No drug interventions Not Available Not Available completed NCT06378580
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma Not Available Not Available completed NCT06307080
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis No drug interventions treatment Not Available recruiting NCT02648880
Preoperative Exercise in Pancreatic Cancer No drug interventions supportive_care Not Available completed NCT02734680
IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT04927780
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer treatment 3 recruiting NCT01218880
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer No drug interventions treatment 1 unknown_status NCT00003780
Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas treatment 2 unknown_status NCT05083780
Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer treatment 1 active_not_recruiting NCT00901680
Creation of the BioBank, Early Detection and Discovery Biomarkers No drug interventions Not Available Not Available completed NCT01104129
Stool Testing for Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00003029
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas treatment 3 completed NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT04294589
Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events No drug interventions Not Available Not Available unknown_status NCT04087889
Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer Not Available Not Available no_longer_available NCT05924789
Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America No drug interventions Not Available Not Available recruiting NCT05218889
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer treatment 1 / 2 recruiting NCT00002689
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer treatment 2 completed NCT03774589
Bilioenteric Anastomosis by Magnetic Compressive Technique No drug interventions treatment Not Available unknown_status NCT03435289
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer treatment 1 unknown_status NCT00116389
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas treatment 2 terminated NCT01088789
A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine treatment 2 active_not_recruiting NCT00557492
Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer treatment 2 completed NCT00836992
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer No drug interventions Not Available Not Available completed NCT04447092
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer treatment 2 active_not_recruiting NCT02465892
Pillars4Life Trial No drug interventions supportive_care Not Available completed NCT05887492
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors treatment 1 / 2 recruiting NCT03621644
Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available active_not_recruiting NCT00547144
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer treatment 1 completed NCT01485744
LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer treatment 1 completed NCT02894944
Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer No drug interventions treatment 1 completed NCT03820544
SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice No drug interventions supportive_care Not Available terminated NCT00950144
Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer No drug interventions Not Available Not Available completed NCT05271344
Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion. No drug interventions prevention Not Available recruiting NCT02926040
Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT04025840
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery supportive_care 4 recruiting NCT00576940
Standard and Immunostimulating Enteral Nutrition in Surgical Patients No drug interventions treatment 4 completed NCT00588640
Study of D-Methadone in Patients With Chronic Pain treatment 1 / 2 completed NCT00294840
Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment No drug interventions Not Available Not Available completed NCT00658840
Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma treatment 2 unknown_status NCT03382340
IMX-110 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT02955940
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib treatment 2 active_not_recruiting NCT05052567
CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 / 2 completed NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT05872867
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) treatment 1 recruiting NCT01129167
Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT00051467
A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer No drug interventions treatment 3 completed NCT01160367
Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life No drug interventions supportive_care Not Available completed NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue No drug interventions treatment Not Available recruiting NCT06388967
Pancreatic Cancer Detection Consortium No drug interventions Not Available Not Available recruiting NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT02449967
HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer No drug interventions treatment 1 / 2 withdrawn NCT00006467
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas treatment 2 completed NCT05583201
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors No drug interventions treatment 0 recruiting NCT00614601
Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer No drug interventions treatment 2 terminated NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT02581501
Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer treatment 1 withdrawn NCT01130701
A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . . No drug interventions treatment 2 withdrawn NCT00658801
Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma No drug interventions treatment 1 terminated NCT01423604
Study of Ruxolitinib in Pancreatic Cancer Patients treatment 2 completed NCT00968604
C-VISA BikDD: Liposome in Advanced Pancreatic Cancer No drug interventions treatment 1 withdrawn NCT03008304
High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT00550004
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine health_services_research 2 terminated NCT01240304
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas treatment 2 terminated NCT00521404
Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer treatment 2 completed NCT03553004
Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial treatment 2 active_not_recruiting NCT00111904
Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors No drug interventions Not Available Not Available completed NCT06491472
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer treatment 2 recruiting NCT06111872
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. treatment 2 recruiting NCT02283372
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer treatment 1 completed NCT03985072
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor No drug interventions treatment 1 completed NCT01663272
A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer treatment 1 completed NCT00983268
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer treatment 1 completed NCT05132868
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling No drug interventions supportive_care Not Available completed NCT03471468
Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer No drug interventions basic_science Not Available terminated NCT06153368
Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC treatment 2 not_yet_recruiting NCT01396668
Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer treatment 2 completed NCT06001268
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) No drug interventions supportive_care Not Available recruiting NCT00025168
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer treatment 2 completed NCT03460769
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) No drug interventions Not Available Not Available recruiting NCT00005869
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer treatment 3 unknown_status NCT01102569
Pancreatic Cancer Genetics No drug interventions Not Available Not Available recruiting NCT04426669
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering treatment 1 / 2 recruiting NCT01664169
Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303 No drug interventions Not Available Not Available completed NCT03490669
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors No drug interventions treatment 1 completed NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors treatment 1 / 2 terminated NCT03586869
QUILT-3.080: NANT Pancreatic Cancer Vaccine treatment 1 / 2 terminated NCT00524069
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery treatment Not Available withdrawn NCT00871169
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT01876069
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer No drug interventions diagnostic Not Available completed NCT03679169
Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy No drug interventions treatment Not Available recruiting NCT00012246
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract treatment 2 terminated NCT00183846
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers treatment 1 completed NCT04544046
Supportive Oncology Care At Home RCT No drug interventions supportive_care Not Available active_not_recruiting NCT01515046
Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer treatment 2 terminated NCT04993846
Pancreatic Cancer and Oral Microbiome No drug interventions Not Available Not Available unknown_status NCT03982446
Germline Mutations in Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT01833546
A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer treatment 1 completed NCT04398446
Effect of Hemp-CBD on Patients With CIPN treatment 2 unknown_status NCT01531712
Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable treatment 2 terminated NCT05369312
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients No drug interventions treatment 1 not_yet_recruiting NCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer treatment 2 recruiting NCT06129812
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers No drug interventions supportive_care 3 completed NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer No drug interventions treatment 1 / 2 unknown_status NCT00547612
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer No drug interventions diagnostic 1 completed NCT05187312
Registry for Advanced Endoscopy No drug interventions Not Available Not Available recruiting NCT01956812
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer treatment 3 terminated NCT00436410
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer treatment 0 completed NCT00004910
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction No drug interventions supportive_care 1 / 2 completed NCT03989310
An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer treatment 1 / 2 unknown_status NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors treatment 2 active_not_recruiting NCT00478010
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer No drug interventions health_services_research Not Available completed NCT03614910
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System No drug interventions Not Available Not Available completed NCT06055010
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology No drug interventions Not Available Not Available recruiting NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Not Available Not Available available NCT01346410
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer No drug interventions treatment Not Available completed NCT00047710
Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer treatment 1 completed NCT00882310
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer treatment 2 completed NCT02777710
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers treatment 1 completed NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease No drug interventions Not Available Not Available recruiting NCT05703581
Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy No drug interventions Not Available Not Available recruiting NCT01396681
Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer treatment 2 completed NCT01994681
Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air No drug interventions Not Available Not Available unknown_status NCT06456281
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA No drug interventions Not Available Not Available recruiting NCT00006981
Immunotoxin Therapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00898781
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT03225781
Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer No drug interventions treatment Not Available terminated NCT04660695
Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction No drug interventions Not Available Not Available completed NCT03322995
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial treatment 2 recruiting NCT00004895
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery supportive_care 2 completed NCT04109495
Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer Patients No drug interventions other Not Available completed NCT03228095
Volatiles in Breath and Headspace Analysis - Diagnostic Markers No drug interventions Not Available Not Available enrolling_by_invitation NCT01593995
EGF Ointment for Erlotinib Skin Lesion No drug interventions treatment 2 completed NCT00620295
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors treatment 1 completed NCT01459614
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer treatment 2 completed NCT00639314
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy No drug interventions treatment Not Available completed NCT03167814
Prevention of Chyle-leak After Major Pancreatic Surgery No drug interventions prevention Not Available recruiting NCT06202014
Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC No drug interventions treatment 2 recruiting NCT04133155
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer Not Available Not Available completed NCT00002955
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas treatment 2 completed NCT03331055
PENS or TENS for Pain in Pancreatic Cancer No drug interventions treatment Not Available completed NCT06256055
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT04257955
COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer No drug interventions Not Available Not Available completed NCT01132755
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage No drug interventions diagnostic 2 completed NCT06513455
Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer treatment 1 / 2 not_yet_recruiting NCT06319755
Characteristics of Intestinal Microbiome Following Pancreatic Surgery No drug interventions Not Available Not Available not_yet_recruiting NCT04148755
The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions No drug interventions Not Available Not Available unknown_status NCT00851955
Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer No drug interventions Not Available Not Available completed NCT04161755
Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery treatment 1 active_not_recruiting NCT03757455
ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy No drug interventions treatment Not Available terminated NCT03127150
Chyle Leak After Pancreatic Operation No drug interventions Not Available Not Available unknown_status NCT00733850
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer treatment 2 completed NCT05859750
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT04258150
Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer treatment 2 terminated NCT04883450
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04089150
MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease treatment 2 unknown_status NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) treatment 1 / 2 recruiting NCT03494023
EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice No drug interventions Not Available Not Available completed NCT05945823
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors treatment 2 recruiting NCT06528223
Research of the Application of Artificial Intelligence Model "PANDA" No drug interventions diagnostic Not Available not_yet_recruiting NCT01693523
Minocycline Study in Pancreatic Cancer Patients treatment 2 completed NCT04352023
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural No drug interventions treatment 2 unknown_status NCT05052723
Cabozantinib and Pembrolizumab in Metastatic Pancreas treatment 2 active_not_recruiting NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis No drug interventions Not Available Not Available recruiting NCT00920023
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) diagnostic 4 completed NCT00556023
A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer treatment 1 completed NCT03600623
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer treatment 0 terminated NCT05606523
Microbiota and Pancreatic Cancer Cachexia No drug interventions Not Available Not Available recruiting NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics No drug interventions treatment Not Available recruiting NCT03334708
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT06054308
Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study No drug interventions treatment Not Available withdrawn NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking treatment 4 completed NCT04155008
Nutrition and Pharmacological Algorithm for Oncology Patients Study supportive_care 4 terminated NCT01523808
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer treatment 1 completed NCT00461708
A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival treatment 2 completed NCT05400408
Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study No drug interventions diagnostic Not Available not_yet_recruiting NCT03536208
Biological Effect of Warfarin on Pancreatic Cancer treatment 0 withdrawn NCT04893408
Pancreatic Surgery in Elderly Patients No drug interventions Not Available Not Available completed NCT03519308
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer treatment 0 terminated NCT05689138
Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01167738
Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer treatment 2 terminated NCT03366038
Shark Mouth Modified Pancreaticojejunostomy No drug interventions Not Available Not Available unknown_status NCT05251038
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer treatment 1 / 2 withdrawn NCT04966143
Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer No drug interventions treatment 0 unknown_status NCT00005843
R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer treatment 2 completed NCT05451043
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) treatment 2 recruiting NCT04348643
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer No drug interventions treatment 1 / 2 unknown_status NCT02588443
Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma treatment 1 completed NCT06276803
The LINFU® U.S. Registry for the in the General Population Without Risk Factors No drug interventions Not Available Not Available not_yet_recruiting NCT00004003
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery treatment 2 completed NCT00026403
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT05903703
Canagliflozin With Gemcitabine in Pancreatic Carcinoma treatment Not Available not_yet_recruiting NCT01473303
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT02506803
Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. treatment 1 unknown_status NCT06289803
The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery No drug interventions treatment Not Available recruiting NCT05583890
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals. No drug interventions Not Available Not Available recruiting NCT04188990
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition No drug interventions treatment Not Available completed NCT01782690
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Not Available Not Available completed NCT03520790
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT06267690
A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC No drug interventions Not Available Not Available completed NCT03871790
Peptide-based Immunization for Colon- and and Pancreas-carcinoma No drug interventions Not Available Not Available completed NCT05184790
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology No drug interventions Not Available Not Available recruiting NCT04907864
Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) supportive_care 2 unknown_status NCT05270564
Post-operative Drainage After Pancreaticoduodenectomy No drug interventions treatment Not Available recruiting NCT00364364
Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. No drug interventions treatment 0 terminated NCT00260364
Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer treatment 1 / 2 completed NCT03623464
RCT of Mobile Apps & FitBit v. Usual Care No drug interventions other Not Available active_not_recruiting NCT02974764
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT06233864
A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 not_yet_recruiting NCT02210364
Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). treatment 1 completed NCT05247164
EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients No drug interventions diagnostic Not Available recruiting NCT04549064
Biomarkers of Pancreatic Cancer and New Way to Detection No drug interventions Not Available Not Available unknown_status NCT00577564
EUS-CPN: A Retrospective Review No drug interventions Not Available Not Available completed NCT03779464
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas treatment 2 unknown_status NCT00511264
Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract No drug interventions Not Available Not Available completed NCT04012021
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI No drug interventions basic_science Not Available unknown_status NCT03417921
A Study of ABTL0812 in Pancreatic Cancer treatment 1 / 2 suspended NCT06249321
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy No drug interventions treatment 2 recruiting NCT05964621
Venous Thromboembolism in Primary Pancreatic Tumour Resection No drug interventions Not Available Not Available recruiting NCT00580021
Clinical Outcomes in Hereditary Cancer No drug interventions Not Available Not Available withdrawn NCT03300921
A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer treatment 1 terminated NCT00125021
Tarceva and Capecitabine for Pancreatic Cancer treatment 2 completed NCT04396821
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT00541021
Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 3 unknown_status NCT00785421
Chemotherapy With or Without Enoxaparin in Pancreatic Cancer treatment 2 / 3 completed NCT01595321
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas treatment 2 completed NCT00602602
Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer treatment 2 completed NCT00600002
Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma No drug interventions treatment 1 completed NCT00394602
Chemoradiation-Induced Nausea and Emesis: Quality of Life No drug interventions Not Available Not Available terminated NCT02869802
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis No drug interventions Not Available Not Available recruiting NCT01995084
In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study No drug interventions diagnostic Not Available completed NCT00033384
CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer treatment 2 completed NCT02934984
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT06054984
TCR-T Cells in the Treatment of Advanced Pancreatic Cancer No drug interventions treatment 0 recruiting NCT00529984
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies No drug interventions treatment 1 / 2 completed NCT02479984
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer No drug interventions treatment Not Available unknown_status NCT00960284
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer treatment 2 / 3 completed NCT01598584
Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer supportive_care 2 / 3 withdrawn NCT01051284
A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer No drug interventions treatment 1 completed NCT02713984
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer No drug interventions treatment 1 / 2 withdrawn NCT02106884
Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel treatment 2 completed NCT02424279
Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder No drug interventions supportive_care Not Available unknown_status NCT03158779
Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer No drug interventions treatment 2 completed NCT05419479
Switch Maintenance in Pancreatic treatment 1 / 2 recruiting NCT03891979
Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma treatment 4 withdrawn NCT00583479
Prospective Study of Celiac Block Injection: 1 vs. 2 No drug interventions treatment 4 completed NCT00743379
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors treatment 1 / 2 completed NCT02117479
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) treatment 3 terminated NCT01945879
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer treatment 1 / 2 completed NCT04743479
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) No drug interventions Not Available Not Available recruiting NCT00004087
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer treatment 1 / 2 completed NCT02241187
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection treatment Not Available completed NCT00889187
Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer treatment 1 / 2 terminated NCT05043987
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers No drug interventions treatment 1 withdrawn NCT00006387
Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer No drug interventions treatment 1 completed NCT03819387
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer No drug interventions treatment 1 completed NCT00376987
Zinc Supplements in Lowering Cadmium Levels in Smokers No drug interventions prevention 2 completed NCT06224387
CTS2190 Phase I /II Clinical Study in Patients No drug interventions treatment 1 / 2 recruiting NCT00569387
Vaccine Study for Surgically Resected Pancreatic Cancer No drug interventions treatment 2 completed NCT03054987
Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction No drug interventions treatment Not Available completed NCT02919787
Nordic Pancreatic Cancer Trial (NorPACT) - 1 treatment 2 / 3 active_not_recruiting NCT01212887
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer treatment 1 terminated NCT04117087
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer treatment 1 recruiting NCT00898287
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer treatment 1 / 2 completed NCT00789633
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer treatment 3 completed NCT03908333
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT04337333
Two-in-one Covered and Uncovered Metal Stent No drug interventions treatment Not Available unknown_status NCT01591733
FOLFIRINOX + RT for Pancreatic Cancer treatment 2 unknown_status NCT02022033
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial No drug interventions treatment 2 completed NCT00040833
Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer No drug interventions supportive_care 2 completed NCT02024633
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer treatment 1 unknown_status NCT00902733
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer No drug interventions health_services_research Not Available completed NCT02293954
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer diagnostic Not Available active_not_recruiting NCT03063554
EUS BD vs ERCP TP for Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT04600154
MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients No drug interventions treatment Not Available recruiting NCT05313854
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data No drug interventions Not Available Not Available unknown_status NCT03415854
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) treatment 2 completed NCT06195254
Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02331251
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) treatment 1 / 2 terminated NCT03187951
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer No drug interventions treatment Not Available active_not_recruiting NCT04083651
A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer treatment 2 / 3 withdrawn NCT03454451
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers treatment 1 completed NCT00003951
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas treatment 2 completed NCT00614653
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer treatment 1 completed NCT00005053
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT05875753
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer No drug interventions diagnostic 0 recruiting NCT00177853
Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer treatment 1 terminated NCT00810953
A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy treatment 1 / 2 completed NCT03009253
Translational Research on Locally Advanced Pancreatic Adenocarcinoma No drug interventions treatment Not Available unknown_status NCT01827553
Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy treatment 3 completed NCT03937453
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus No drug interventions Not Available Not Available recruiting NCT03525353
Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training No drug interventions Not Available Not Available recruiting NCT01236053
Cancer in Patients With Gabapentin (GPRD) Not Available Not Available completed NCT02118077
Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer treatment 3 completed NCT03038477
A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection treatment 2 withdrawn NCT06487377
IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations No drug interventions treatment 1 recruiting NCT06233877
Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer treatment 2 not_yet_recruiting NCT00209677
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer treatment 1 / 2 suspended NCT01104077
Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) No drug interventions Not Available Not Available completed NCT01777477
Adjuvant Effect of Chloroquine on Gemcitabine treatment 1 completed NCT05035147
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer treatment 4 recruiting NCT02580747
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso No drug interventions treatment 1 unknown_status NCT00045747
UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT00582647
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract No drug interventions Not Available Not Available active_not_recruiting NCT02238847
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy No drug interventions treatment Not Available completed NCT05908747
Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer treatment 2 recruiting NCT04686747
COVID - 19 and Advanced Gastro-intestinal Cancer Treatment No drug interventions Not Available Not Available completed NCT02028845
Loop-tipped Guidewire in Selective Biliary Cannulation No drug interventions treatment Not Available completed NCT04034745
Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain Not Available Not Available withdrawn NCT06461598
Signature for Precise Chemosensitivity Prediction in PDAC No drug interventions Not Available Not Available completed NCT02873598
A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer treatment 1 completed NCT04146298
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer treatment 1 / 2 recruiting NCT04395898
Pancreaticoduodenectomy: Outcomes of a Complex Surgical Procedure From a Developing Country No drug interventions Not Available Not Available completed NCT05697198
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine No drug interventions Not Available Not Available recruiting NCT01439698
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry No drug interventions Not Available Not Available unknown_status NCT00681798
Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma treatment 1 completed NCT01845805
Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) treatment 2 completed NCT05519605
Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD No drug interventions Not Available Not Available active_not_recruiting NCT06438705
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors No drug interventions Not Available Not Available recruiting NCT03001505
Registry for Pancreatic Cancer No drug interventions Not Available Not Available withdrawn NCT03749005
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT01770405
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract No drug interventions Not Available Not Available completed NCT01273805
Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study No drug interventions Not Available Not Available recruiting NCT04803305
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia treatment 1 completed NCT00112697
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT05709197
The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy No drug interventions treatment Not Available recruiting NCT01926197
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer treatment 3 completed NCT01059097
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy No drug interventions treatment Not Available completed NCT02486497
Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining No drug interventions treatment Not Available completed NCT00266097
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer treatment 1 completed NCT04847297
Preoperative Biliary Drainage in Malignant Biliary Obstruction No drug interventions Not Available Not Available not_yet_recruiting NCT00636883
Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer treatment 2 terminated NCT00553683
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer treatment 1 / 2 unknown_status NCT03678883
9-ING-41 in Patients With Advanced Cancers treatment 2 active_not_recruiting NCT02465983
Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer treatment 1 terminated NCT00040183
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. treatment 3 completed NCT01657383
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery No drug interventions Not Available Not Available completed NCT00769483
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer treatment 1 / 2 completed NCT03404661
Optical and Biochemical Biomarkers in Early Pancreatic Cancer Not Available Not Available completed NCT04592861
Carbon Ion RT for Locally Advanced Pancreatic Cancer No drug interventions treatment 3 terminated NCT06571461
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer treatment 3 not_yet_recruiting NCT04066361
OPTimizing Treatment Focused Genetic Testing IN Cancer No drug interventions supportive_care Not Available completed NCT00004861
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT01809028
Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions No drug interventions diagnostic Not Available completed NCT03825328
A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) treatment 2 unknown_status NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma treatment 1 recruiting NCT02514928
Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas No drug interventions treatment 3 unknown_status NCT03187028
Diet and Exercise After Pancreatic Cancer No drug interventions supportive_care Not Available completed NCT05632328
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC treatment 2 recruiting NCT02685228
Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer treatment Not Available unknown_status NCT01042028
A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer treatment 1 / 2 terminated NCT02707328
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) treatment 1 terminated NCT05178628
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer prevention 3 recruiting NCT05784311
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) treatment 4 recruiting NCT03933111
Application of Newly Developed Endoscopic Ultrasound With Zone Sonography Technology for Diagnosis of Pancreatic Caner No drug interventions diagnostic Not Available unknown_status NCT00003411
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer treatment 1 completed NCT04281511
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy No drug interventions Not Available Not Available completed NCT00831493
Vorinostat Plus Radiation Therapy in Pancreatic Cancer treatment 1 / 2 terminated NCT00544193
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer treatment 1 completed NCT02131493
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer treatment 2 completed NCT01360593
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma treatment 2 completed NCT06310993
Exercise to Boost Immunity in Advanced Cancer No drug interventions treatment Not Available not_yet_recruiting NCT03642093
HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery No drug interventions treatment 4 unknown_status NCT03638193
Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT06278493
A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer treatment 1 / 2 completed NCT06564571
Artificial Inteligence in Endoscopic Ultrasound No drug interventions Not Available Not Available recruiting NCT00489671
Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis No drug interventions Not Available Not Available completed NCT00831571
Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin No drug interventions Not Available Not Available completed NCT00964171
Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer treatment 2 unknown_status NCT02106871
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer supportive_care 1 withdrawn NCT00159471
Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. treatment Not Available terminated NCT04543071
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma treatment 2 recruiting NCT00583271
A Prospective Study of EUS Guided Celiac Block Not Available Not Available completed NCT02190071
Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02050178
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer treatment 1 completed NCT03434678
Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection treatment 3 completed NCT00526578
Pancreatic Cancer Genetic Epidemiology (PACGENE) Study No drug interventions Not Available Not Available active_not_recruiting NCT06069778
Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma No drug interventions treatment 1 / 2 recruiting NCT00640978
Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer treatment 2 terminated NCT03915678
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors treatment 2 recruiting NCT00585078
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma treatment 2 completed NCT00149578
A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer treatment 2 unknown_status NCT00948688
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas treatment 1 / 2 terminated NCT02155088
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer treatment 1 completed NCT04825288
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT00010088
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct treatment 2 unknown_status NCT06196788
Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer treatment 2 recruiting NCT00805688
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00662688
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer No drug interventions supportive_care 3 terminated NCT01661088
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients No drug interventions treatment 2 completed NCT05755607
A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD No drug interventions treatment Not Available not_yet_recruiting NCT05802407
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT06071507
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy No drug interventions Not Available Not Available recruiting NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies No drug interventions supportive_care Not Available completed NCT01492907
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer No drug interventions diagnostic 1 completed NCT02818907
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable No drug interventions other Not Available unknown_status NCT05379907
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer No drug interventions Not Available Not Available withdrawn NCT02242409
Study of Gemcitabine and Abraxane for Pancreas Cancer treatment 2 terminated NCT03821909
Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS No drug interventions Not Available Not Available unknown_status NCT02416609
Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT01188109
Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision treatment 2 terminated NCT01662609
Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available completed NCT04276909
Feasibility Study of LUM Imaging System for Pancreatic Cancer No drug interventions other Not Available withdrawn NCT00369109
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors No drug interventions Not Available Not Available completed NCT00739609
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors treatment 1 terminated NCT00280709
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction No drug interventions treatment 4 completed NCT02295956
Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer No drug interventions supportive_care 0 completed NCT02704156
SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer No drug interventions treatment 2 completed NCT00438256
Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer treatment 1 / 2 completed NCT04235556
Integrated Care Pathway in Oncology (PASSION) No drug interventions Not Available Not Available unknown_status NCT05740956
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01102556
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease No drug interventions Not Available Not Available recruiting NCT06405685
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis treatment 2 recruiting NCT01487785
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients treatment 1 completed NCT01188785
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas treatment 1 completed NCT00683085
Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 terminated NCT00655785
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) treatment 1 / 2 completed NCT02405585
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer treatment 2 terminated NCT05057715
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer treatment 1 recruiting NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs Not Available Not Available not_yet_recruiting NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy No drug interventions Not Available Not Available completed NCT00233415
Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer No drug interventions treatment 2 completed NCT02707315
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer treatment 0 unknown_status NCT00489515
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder No drug interventions Not Available Not Available completed NCT05737615
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 No drug interventions diagnostic 1 recruiting NCT03801915
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers No drug interventions treatment 2 completed NCT01127815
Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT02005315
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer treatment 1 completed NCT02581215
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer treatment 2 active_not_recruiting NCT04683315
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples treatment 2 recruiting NCT04476537
RNA Precision Oncology in Advanced Pancreatic Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT03302637
Oral Microbiome and Pancreatic Cancer No drug interventions Not Available Not Available completed NCT04776837
Predicting Disease Progression and/or Recurrence in Cancer No drug interventions Not Available Not Available completed NCT03180437
Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT01940237
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer No drug interventions treatment Not Available terminated NCT05729737
Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT02154737
Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer treatment 1 completed NCT02539537
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma treatment 3 completed NCT04605237
Pancreatic Cancer Recurrence in the Netherlands No drug interventions Not Available Not Available recruiting NCT00031837
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer treatment 3 terminated NCT00056537
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer treatment 1 completed NCT00587132
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma diagnostic 1 / 2 terminated NCT04136132
Prospective Monocentric Clinical-biological Database No drug interventions other Not Available recruiting NCT00005832
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT01333332
Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer treatment 2 unknown_status NCT02578732
FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial treatment 2 completed NCT03634332
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC treatment 2 unknown_status NCT05043532
Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT00897832
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00462852
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT00630552
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT02767752
Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer treatment 2 terminated NCT02459652
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer No drug interventions treatment 2 completed NCT00427752
Abdominal Exploration Without Incisions No drug interventions diagnostic 0 completed NCT01446952
Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects prevention 1 completed NCT05395052
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors treatment 1 terminated NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors No drug interventions treatment 1 recruiting NCT03572400
Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer treatment 2 active_not_recruiting NCT05396300
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT05102500
Second Opinions in Oncology No drug interventions Not Available Not Available completed NCT04518800
PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer No drug interventions prevention Not Available unknown_status NCT00202800
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT02021500
A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. Not Available Not Available completed NCT02047500
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer treatment 1 terminated NCT02841800
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis No drug interventions treatment Not Available completed NCT03319459
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors treatment 1 completed NCT03770559
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients No drug interventions treatment Not Available recruiting NCT05292859
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs No drug interventions Not Available Not Available active_not_recruiting NCT04203459
The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation No drug interventions Not Available Not Available unknown_status NCT00919659
Parenteral Nutrition Support for Patients With Pancreatic Cancer No drug interventions supportive_care 2 completed NCT01303159
Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer No drug interventions treatment Not Available terminated NCT05438459
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites No drug interventions treatment 1 / 2 recruiting NCT05420259
Combined Exercise and Nutritional Intervention in GI Cancer Patients No drug interventions other Not Available recruiting NCT03627559
Early Detection of Anastomotic Leakage by Microdialysis Catheters No drug interventions Not Available Not Available completed NCT00902759
Fatigue and Pancreas and Bile Duct Cancer Study No drug interventions supportive_care 0 completed NCT05249075
Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy No drug interventions Not Available Not Available recruiting NCT06359275
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients treatment 2 recruiting NCT00968175
Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer No drug interventions Not Available Not Available completed NCT03469375
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00108875
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer No drug interventions treatment 1 / 2 unknown_status NCT05483075
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer No drug interventions supportive_care Not Available recruiting NCT00032175
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 3 completed NCT01913275
Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy No drug interventions treatment Not Available withdrawn NCT00002475
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer treatment 2 completed NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05415475
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT00024375
DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer treatment 2 unknown_status NCT01025570
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer treatment 1 terminated NCT00414570
An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs No drug interventions diagnostic 0 terminated NCT00010270
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer No drug interventions treatment 1 unknown_status NCT05596370
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer No drug interventions Not Available Not Available recruiting NCT02541370
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 No drug interventions treatment 1 / 2 completed NCT03184870
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors treatment 1 / 2 completed NCT03435770
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms No drug interventions treatment Not Available unknown_status NCT03685370
PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique No drug interventions other Not Available unknown_status NCT04560270
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer No drug interventions diagnostic Not Available completed NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd) No drug interventions Not Available Not Available recruiting NCT02678442
Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle No drug interventions diagnostic Not Available completed NCT06387342
Namodenoson Treatment of Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT00192842
Gemcitabine With Curcumin for Pancreatic Cancer treatment 2 completed NCT04763642
The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone No drug interventions treatment Not Available active_not_recruiting NCT00350142
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer treatment 2 completed NCT03316599
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer treatment 1 completed NCT04390399
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer treatment 2 active_not_recruiting NCT00386399
Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene diagnostic 2 withdrawn NCT00923299
Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine treatment 1 / 2 completed NCT00456599
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer treatment 2 completed NCT00238199
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer treatment 2 completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT03017599
Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study No drug interventions diagnostic Not Available completed NCT06268106
Graphic Novel for Patients Undergoing EUS-FNB No drug interventions health_services_research Not Available not_yet_recruiting NCT00966706
Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer treatment 2 completed NCT01815606
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm No drug interventions diagnostic Not Available completed NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT02598349
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas treatment 2 recruiting NCT01931449
Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy No drug interventions treatment 3 unknown_status NCT00320749
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer treatment 1 completed NCT06205849
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer treatment 1 recruiting NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT02694536
A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer treatment 3 completed NCT02841436
A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available completed NCT01897636
Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT04916236
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers treatment 1 unknown_status NCT01317836
PET-CT in Diagnosis of Pancreatic Cystic Neoplasms No drug interventions Not Available Not Available completed NCT04484636
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) No drug interventions other Not Available recruiting NCT01202136
The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study No drug interventions Not Available Not Available completed NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT04112836
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT01276613
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas treatment 0 terminated NCT00529113
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer treatment 1 terminated NCT01488513
ABC294640 in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT05141513
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma No drug interventions treatment 1 recruiting NCT00570713
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer treatment 2 completed NCT00553813
A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer treatment 2 terminated NCT05114213
MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC No drug interventions treatment 2 unknown_status NCT00679913
Standardization of Surgery on the Pancreatic Cancer No drug interventions treatment 3 completed NCT00019513
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas treatment 1 completed NCT00176813
Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer treatment 2 completed NCT02055313
Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival No drug interventions Not Available Not Available completed NCT00003018
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer treatment 2 completed NCT02347618
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer No drug interventions treatment Not Available completed NCT03668418
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos Not Available Not Available unknown_status NCT00965718
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer No drug interventions treatment 2 completed NCT03552718
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. No drug interventions treatment 1 active_not_recruiting NCT05223218
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study No drug interventions Not Available Not Available enrolling_by_invitation NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT01397019
Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours treatment 2 completed NCT03497819
Autologous CARTmeso/19 Against Pancreatic Cancer treatment 0 unknown_status NCT05642819
REVOLUTION Surgery (REVOLUTION Surgery) No drug interventions Not Available Not Available recruiting NCT02355119
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer treatment 3 unknown_status NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT03699319
CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT00810719
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer treatment 2 completed NCT00275119
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 unknown_status NCT01898741
Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT00897741
Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02459041
Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes No drug interventions Not Available Not Available completed NCT04340141
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer treatment 3 recruiting NCT00761241
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT treatment 2 completed NCT01929941
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies treatment 1 terminated NCT02245217
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients No drug interventions diagnostic Not Available completed NCT06384417
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 No drug interventions supportive_care Not Available recruiting NCT04624217
A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer treatment 1 / 2 completed NCT01384617
Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy No drug interventions prevention Not Available completed NCT05415917
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy treatment 2 recruiting NCT01658917
Collecting Solid Tumor Tissue to Identify New Treatments No drug interventions Not Available Not Available completed NCT05356117
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial No drug interventions screening Not Available recruiting NCT01926717
A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct No drug interventions Not Available Not Available unknown_status NCT01470417
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma treatment 2 completed NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT02791334
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors treatment 1 active_not_recruiting NCT01587534
Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) No drug interventions treatment 2 completed NCT01256034
Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy No drug interventions prevention 4 completed NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) No drug interventions Not Available Not Available recruiting NCT06291324
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment No drug interventions Not Available Not Available recruiting NCT00053924
Perifosine in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT01138124
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) Not Available Not Available completed NCT06258824
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers No drug interventions Not Available Not Available completed NCT00862524
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer treatment 1 / 2 completed NCT00089024
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer treatment 2 completed NCT05989724
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors treatment 2 recruiting NCT03207724
Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia treatment 1 completed NCT04371224
NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer treatment 2 recruiting NCT02395016
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer treatment 3 completed NCT05013216
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer prevention 1 recruiting NCT00900016
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery No drug interventions Not Available Not Available completed NCT00234416
IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer treatment 1 / 2 completed NCT02722616
Ultrasound Monitoring of Abdominal Soft Tissue No drug interventions diagnostic Not Available terminated NCT00003216
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas treatment 3 completed NCT04196816
Surgery for Pancreatic Cancer With Oligo-Metastasis No drug interventions Not Available Not Available completed NCT03351296
Two Chemotherapy Regimens Plus or Minus Bevacizumab treatment 2 active_not_recruiting NCT02909296
Endoscopic Drainage of Collections After Pancreatic Surgery No drug interventions Not Available Not Available completed NCT05827796
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer treatment 1 / 2 recruiting NCT03716596
SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients treatment 1 unknown_status NCT04584996
CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers No drug interventions Not Available Not Available unknown_status NCT00903396
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer supportive_care 2 terminated NCT02705196
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer treatment 1 / 2 recruiting NCT00813696
Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer treatment 3 unknown_status NCT00551096
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors treatment 1 completed NCT00696696
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer treatment 2 completed NCT06001658
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers treatment 2 recruiting NCT04431258
ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study treatment 1 / 2 completed NCT04595058
LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent No drug interventions treatment Not Available completed NCT06259058
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer treatment 1 / 2 not_yet_recruiting NCT01984658
A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients treatment 1 completed NCT00429858
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer treatment 2 terminated NCT06334458
Epigenomic and Machine Learning Models to Predict Pancreatic Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT00626158
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers treatment 1 completed NCT02366858
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures No drug interventions diagnostic Not Available withdrawn NCT00683358
Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 unknown_status NCT00997958
Study of CellCept for Advanced Pancreatic Cancer treatment 1 completed NCT03469258
Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma supportive_care 2 terminated NCT06196658
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer No drug interventions treatment 0 not_yet_recruiting NCT00303758
Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT03724435
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry No drug interventions Not Available Not Available terminated NCT02449135
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma No drug interventions Not Available Not Available no_longer_available NCT03649035
Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma No drug interventions treatment 3 withdrawn NCT02481635
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT00841035
7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients treatment 2 terminated NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT06403735
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01094535
Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery screening Not Available withdrawn NCT00837135
GI-4000 With Adoptive Transfer in Pancreatic Cancer treatment 1 withdrawn NCT02988635
Early Palliative Care on Quality of Life of Advanced Cancer Patients No drug interventions supportive_care 3 completed NCT00176735
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer treatment Not Available terminated NCT00033735
Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer treatment 3 completed NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT00584363
Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection No drug interventions Not Available Not Available completed NCT00603863
Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer treatment 1 / 2 completed NCT02119663
A Study of Ruxolitinib in Pancreatic Cancer Patients treatment 3 terminated NCT03350763
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents? No drug interventions treatment Not Available withdrawn NCT03816163
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer treatment 2 active_not_recruiting NCT00671463
Pancreatic Stent to Prevent Leak After Distal Pancreatectomy No drug interventions prevention Not Available withdrawn NCT04338763
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer treatment 1 recruiting NCT02332863
Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. No drug interventions treatment Not Available completed NCT01248663
Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery No drug interventions prevention Not Available completed NCT02702986
Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) No drug interventions treatment 1 completed NCT05393986
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors No drug interventions treatment 1 recruiting NCT01161186
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma treatment 1 completed NCT00499486
Sirolimus in Treating Patients With Advanced Pancreatic Cancer treatment 2 completed NCT00625586
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer treatment 2 terminated NCT00075686
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer treatment 3 completed NCT04327986
Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer treatment 1 / 2 terminated NCT00628186
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy No drug interventions treatment Not Available completed NCT01583686
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer treatment 1 / 2 terminated NCT04334239
Effectiveness of Care in Certified Cancer Centres in Germany No drug interventions Not Available Not Available completed NCT00837239
Huachansu & Gemcitabine in Pancreatic Cancer treatment 2 completed NCT00379639
A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors treatment 1 completed NCT00338039
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients treatment 2 completed NCT03697239
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT02423239
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours treatment 1 unknown_status NCT03104439
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer treatment 2 recruiting NCT02489422
Programs To Support You During Chemotherapy No drug interventions supportive_care Not Available completed NCT02246322
A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. No drug interventions diagnostic Not Available unknown_status NCT01730222
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma treatment 1 / 2 completed NCT03023722
Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer treatment 2 completed NCT01640522
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms No drug interventions supportive_care Not Available completed NCT00622622
Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer treatment 1 completed NCT04137822
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer Not Available Not Available no_longer_available NCT01683422
Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available terminated NCT00053222
Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine treatment 2 completed NCT02921022
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma treatment Not Available active_not_recruiting NCT06177522
Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer treatment 2 recruiting NCT03460925
Improving REsectability in Pancreatic NEoplasms (IRENE) No drug interventions treatment Not Available unknown_status NCT00003025
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer treatment 1 completed NCT01521325
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers basic_science 1 completed NCT00639925
Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer treatment 1 unknown_status NCT05212025
Adavosertib and Gemcitabine in Advanced Pancreatic treatment 2 withdrawn NCT00498225
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer treatment 3 completed NCT04588025
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response No drug interventions diagnostic Not Available recruiting NCT00026130
Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer treatment 2 completed NCT06361030
Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT04612530
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer treatment 1 recruiting NCT06245330
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01505530
A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer treatment 2 completed NCT03410030
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) treatment 1 / 2 completed NCT01150630
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer treatment 2 completed NCT04420130
A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009） treatment Not Available withdrawn NCT05519930
Pancreatic Cancer Early Detection Registry No drug interventions Not Available Not Available suspended NCT02657330
Study of SBP-101 in Pancreatic Cancer treatment 1 completed NCT05677048
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention No drug interventions health_services_research Not Available recruiting NCT02092948
Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer No drug interventions diagnostic 1 completed NCT00660348
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer supportive_care Not Available terminated NCT03829748
Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions No drug interventions diagnostic Not Available completed NCT01080248
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer treatment 2 terminated NCT00387348
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer supportive_care 3 terminated NCT04678648
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT04299048
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. treatment 1 completed NCT00885248
Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT04517448
Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy No drug interventions Not Available Not Available unknown_status NCT02159248
Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation treatment 1 withdrawn NCT03329248
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy treatment 1 / 2 active_not_recruiting NCT03645148
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer No drug interventions treatment 1 completed NCT03563248
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer treatment 2 active_not_recruiting NCT00049348
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer treatment 2 completed NCT00376948
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 2 completed NCT02237157
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer other 1 completed NCT00830557
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders No drug interventions Not Available Not Available recruiting NCT04386057
LY3214996 +/- HCQ in Pancreatic Cancer treatment 2 completed NCT03983057
Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer No drug interventions treatment 3 recruiting NCT03941457
Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer treatment 1 / 2 unknown_status NCT05380557
ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing No drug interventions Not Available Not Available terminated NCT03498326
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer treatment 2 recruiting NCT00005926
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas treatment 2 completed NCT05010226
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry No drug interventions Not Available Not Available not_yet_recruiting NCT00867126
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine treatment 0 terminated NCT05391126
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care treatment Not Available recruiting NCT00548626
Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer No drug interventions diagnostic Not Available completed NCT02639026
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers treatment 1 completed NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT03058926
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT00338026
A Phase I Study of ECO-4601 in Patients With Advanced Cancer treatment 1 completed NCT04247126
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors treatment 1 completed NCT01703026
Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses No drug interventions Not Available Not Available completed NCT00652366
A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT02811666
Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers No drug interventions prevention Not Available unknown_status NCT00593866
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer treatment 1 / 2 completed NCT03475966
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program No drug interventions supportive_care Not Available unknown_status NCT03882866
Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT02695966
EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02947165
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. treatment 1 completed NCT04503265
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT05044065
Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) No drug interventions supportive_care Not Available recruiting NCT03099265
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma treatment 2 terminated NCT06134765
Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer prevention 2 not_yet_recruiting NCT00079365
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas treatment Not Available unknown_status NCT00460174
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer treatment 2 completed NCT00536874
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery treatment 2 completed NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT05631574
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer No drug interventions treatment 1 recruiting NCT06570174
Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients No drug interventions supportive_care Not Available completed NCT00019474
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer treatment 2 completed NCT00622674
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00410774
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery treatment 1 / 2 terminated NCT01721174
Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures No drug interventions treatment Not Available terminated NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01015820
Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer No drug interventions diagnostic Not Available completed NCT05764720
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach No drug interventions treatment Not Available recruiting NCT01214720
A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer treatment 3 completed NCT04421820
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT01929720
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors No drug interventions supportive_care Not Available completed NCT05727020
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT00898482
Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants No drug interventions Not Available Not Available completed NCT01362582
Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer treatment 3 terminated NCT02682082
EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer supportive_care Not Available terminated NCT01569282
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer No drug interventions treatment Not Available withdrawn NCT00059982
Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer treatment 2 completed NCT02706782
A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma No drug interventions treatment 1 unknown_status NCT03848182
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer screening 2 terminated NCT00661882
Pancreatic Cancer Collaborative Registry No drug interventions Not Available Not Available completed NCT05736731
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT02872831
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle No drug interventions treatment Not Available terminated NCT03576131
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT02723331
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates treatment 2 active_not_recruiting NCT05093231
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer treatment 2 not_yet_recruiting NCT00197431
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer treatment 2 unknown_status NCT02514031
ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer other 1 terminated NCT06141031
Trial of Radiotherapy in Combination With TTI-101 in Patients With Borderline Resectable Pancreatic Cancer treatment 1 / 2 recruiting NCT05934331
A LM-302 Combined With Toripalimab Phase II Study treatment 2 recruiting NCT00019331
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors treatment 2 completed NCT01182831
Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas No drug interventions treatment 1 unknown_status NCT00044031
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma treatment 3 completed NCT03906331
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation Not Available Not Available available NCT04682431
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors treatment 1 terminated NCT00490373
Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic treatment 2 completed NCT03250273
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma treatment 2 completed NCT05604573
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT00674973
A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer treatment 2 completed NCT06375473
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients Not Available Not Available not_yet_recruiting NCT03644173
Personal Resilience Empowerment Program Study No drug interventions supportive_care Not Available completed NCT05188573
EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients No drug interventions screening Not Available not_yet_recruiting NCT03267173
Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. No drug interventions treatment 0 unknown_status NCT00882973
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer No drug interventions treatment 1 completed NCT05438927
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04205227
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors treatment 1 / 2 active_not_recruiting NCT00601627
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery treatment 2 completed NCT03940027
EUS-guided Celiac Plexus Neurolysis for the Treatment of Abdominal Pain in Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT00003427
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer treatment 1 completed NCT01314027
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer treatment 3 terminated NCT01445327
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers No drug interventions Not Available Not Available terminated NCT01900327
Neoadjuvant Treatment in Resectable Pancreatic Cancer treatment 3 terminated NCT03033927
Predicting Effective Therapy in Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00424827
A Trial of Chemo & Radiation Therapy for Pancreatic Cancer treatment 2 completed NCT01392027
Biospecimens for Identification of Diseases of the Pancreas. No drug interventions prevention Not Available completed NCT02651727
Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects treatment 1 terminated NCT00265876
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery treatment 1 / 2 completed NCT04241276
A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer treatment 2 active_not_recruiting NCT00057876
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer treatment 3 completed NCT06436976
The Effect of Probiotics ATG-F4 in Cancer Patients supportive_care 2 recruiting NCT05783076
SBRT Plus vNKT for Pancreatic Cancer No drug interventions treatment 2 recruiting NCT05573776
A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy No drug interventions supportive_care Not Available completed NCT05131776
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. No drug interventions treatment 2 / 3 recruiting NCT06283576
Pancreatic Cancer Initial Detection Via Liquid Biopsy No drug interventions Not Available Not Available enrolling_by_invitation NCT03311776
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC") No drug interventions Not Available Not Available recruiting NCT04581876
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer treatment 2 unknown_status NCT02368860
OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma treatment 1 completed NCT03960060
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT00486460
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer Not Available 3 unknown_status NCT01304160
Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT03098160
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab treatment 1 unknown_status NCT00425360
Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer treatment 3 completed NCT04862260
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma treatment 0 active_not_recruiting NCT05604560
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer treatment 2 recruiting NCT04976660
TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT03869294
GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients No drug interventions Not Available Not Available completed NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05399394
Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT00099294
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer treatment 3 completed NCT00325494
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer treatment 1 completed NCT04931394
Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer No drug interventions treatment 3 recruiting NCT05802394
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT05616494
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer treatment 2 recruiting NCT01327794
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer No drug interventions Not Available Not Available completed NCT00003591
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer treatment 2 completed NCT03214991
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT01111591
Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer treatment 4 unknown_status NCT03637491
A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors treatment 1 / 2 terminated NCT02551991
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma treatment 2 completed NCT03146962
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies treatment 2 completed NCT00024362
BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery No drug interventions treatment 2 unknown_status NCT03286062
VM110 in Detection of Microscopic Tumors: A Phase I Study No drug interventions diagnostic 1 terminated NCT03991962
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma No drug interventions treatment 2 recruiting NCT04105062
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery No drug interventions diagnostic 1 / 2 withdrawn NCT00010062
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer treatment 2 unknown_status NCT00082862
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer treatment 2 unknown_status NCT00709462
A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) No drug interventions treatment 1 completed NCT03704662
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma No drug interventions treatment Not Available recruiting NCT01209962
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response No drug interventions Not Available Not Available completed NCT05275062
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma No drug interventions treatment 0 unknown_status NCT03192462
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT05360680
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers No drug interventions treatment 1 active_not_recruiting NCT03042780
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas treatment 2 terminated NCT03400280
POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection No drug interventions treatment Not Available unknown_status NCT00112580
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT01189929
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer treatment 1 completed NCT00597129
Safety and Efficacy Study of 90Y-hPAM4 at Different Doses treatment 1 / 2 completed NCT02713529
Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer treatment 1 / 2 completed NCT01821729
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer treatment 2 unknown_status NCT01219829
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT06409429
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer treatment 2 / 3 not_yet_recruiting NCT04892329
A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS No drug interventions screening Not Available unknown_status NCT06079229
Quality of Life in Elderly Patients After Pancreatic Cancer Surgery No drug interventions Not Available Not Available completed NCT00252889
Doxil Topotecan Doublet Cancer Study treatment 1 completed NCT04571489
A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer treatment 2 unknown_status NCT04449289
Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery treatment 2 not_yet_recruiting NCT03058289
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 treatment 1 / 2 completed NCT01219192
Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure No drug interventions treatment 1 unknown_status NCT01867892
A Phase II Study of Locally Advanced Pancreatic Cancer treatment 2 unknown_status NCT05810792
Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer treatment 2 not_yet_recruiting NCT06499792
Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy No drug interventions Not Available Not Available recruiting NCT00409292
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer treatment 2 completed NCT00040092
A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer treatment 3 completed NCT03140592
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue No drug interventions Not Available Not Available unknown_status NCT06391892
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery No drug interventions treatment 3 recruiting NCT02478892
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk No drug interventions Not Available Not Available recruiting NCT04131192
Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer treatment 1 terminated NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT02584244
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers No drug interventions diagnostic 1 / 2 recruiting NCT00372944
AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy treatment 2 completed NCT05132244
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT00276744
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer treatment 2 terminated NCT01656044
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer No drug interventions supportive_care Not Available completed NCT04245644
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study No drug interventions Not Available Not Available active_not_recruiting NCT01098344
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT00365144
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine treatment 2 completed NCT01995240
Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study diagnostic Not Available completed NCT01761240
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC treatment 1 completed NCT00463840
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer treatment 1 / 2 terminated NCT06094140
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer treatment 2 recruiting NCT03407040
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy No drug interventions Not Available Not Available terminated NCT04007640
Early Screening of Pancreatic Lesions : Development of New Imaging Tools No drug interventions diagnostic Not Available unknown_status NCT02454140
Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer No drug interventions other Not Available completed NCT06541340
A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice No drug interventions treatment Not Available recruiting NCT05012540
SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI) No drug interventions Not Available Not Available completed NCT06404840
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study treatment 2 recruiting NCT00436267
Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery treatment 2 unknown_status NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) No drug interventions treatment Not Available recruiting NCT03525067
Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies No drug interventions Not Available Not Available completed NCT03207867
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma treatment 2 terminated NCT00440167
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine treatment 3 unknown_status NCT02940067
Enhancing Fitness Before Pancreatic Surgery No drug interventions other Not Available completed NCT00896467
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy No drug interventions Not Available Not Available terminated NCT05438667
TCR-T Cell Therapy on Advanced Pancreatic Cancer No drug interventions treatment 0 recruiting NCT06156267
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino treatment 0 not_yet_recruiting NCT04674267
Resilience and Equity in Aging, Cancer, and Health (REACH) No drug interventions health_services_research Not Available recruiting NCT01056601
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy treatment 2 terminated NCT05305001
Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico No drug interventions Not Available Not Available compl